发明名称 |
Ophthalmic Lipophilic and Hydrophilic Drug Delivery Vehicle Formulations |
摘要 |
The ophthalmic drug delivery vehicles provide comfort and compliance; drug solubility, residence time and permeability; and reduce side effects. In addition, the delivery vehicle can be slightly modified to provide an artificial tear formulation. |
申请公布号 |
US2014378401(A1) |
申请公布日期 |
2014.12.25 |
申请号 |
US201314132822 |
申请日期 |
2013.12.18 |
申请人 |
GNT, LLC |
发明人 |
Horn Gerald |
分类号 |
A61K47/38;A61K31/4174;A61K47/02;A61K47/18;A61K31/138;A61K31/542;A61K31/546;A61K38/13;A61K31/498;A61K31/55;A61K31/724;A61K31/7052;A61K31/47;A61K31/4439;A61K31/4709;A61K31/53;A61K31/444;A61K47/34 |
主分类号 |
A61K47/38 |
代理机构 |
|
代理人 |
|
主权项 |
1. An ophthalmic drug delivery composition comprising from about 1% to about 15% w/v nonionic surfactant, one or more non-Newtonian high blend viscosity enhancing, non-gelling agents and from about 0.025% to about 0.90% sodium chloride, such that:
i. final composition viscosity at shear rates representative of a non-blinking eye is between 50 and 100 cps; ii. final composition viscosity at shear rates representative of a blinking eye of less than 30 cps but remaining above 5 cps, even after 30% dilution; and iii. a final composition ratio of i./ii. of 3:1 or greater,wherein w/v denotes weight by volume. |
地址 |
Dana Point CA US |